SOPHiA GENETICS sells a cloud based software platform that analyzes medical data for hospitals, labs and drug companies. SOPH reports earnings on Tue, Nov 3, 2026. In the past 30 days there were 1 dark pool print.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Aug 5 | HC Wainwright & Co. | Target raised | Buy | |
| Aug 5 | BTIG | Target raised | Buy | |
| Jul 20 | HC Wainwright & Co. | Initiated | Buy | |
| Jun 15 | BTIG | Reiterated | Buy |
Seasonality
How SOPH has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.
Whale Options Flow
90DNo whale options trades in SOPH in the last 90 days.
Dark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SOPH is in one of them and how their past SOPH trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered SOPH in an article yet. Here's the latest on the wider market.
About SOPHiA GENETICS SA
SOPHiA GENETICS is a software company based in Rolle, Switzerland. Its cloud based platform, SOPHiA DDM, standardizes and analyzes health data such as genomic, radiomic and clinical information, so institutions can share insights without moving their samples or data. The company sells mainly to hospitals, clinical and research laboratories, and biopharmaceutical companies.
- Headquarters
- Rolle, Switzerland